Ann Varanakis - 06 Mar 2025 Form 4/A - Amendment Insider Report for LifeStance Health Group, Inc. (LFST)

Role
Chief People Officer
Signature
By: /s/ Ryan Pardo, Attorney-in-Fact
Issuer symbol
LFST
Transactions as of
06 Mar 2025
Transactions value $
-$172,730
Form type
4/A - Amendment
Filing time
12 Nov 2025, 18:37:31 UTC
Date Of Original Report
10 Mar 2025
Previous filing
27 Aug 2024
Next filing
19 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Varanakis Ann Chief People Officer C/O LIFESTANCE HEALTH GROUP, INC., 4800 N. SCOTTSDALE ROAD, SUITE 2500, SCOTTSDALE By: /s/ Ryan Pardo, Attorney-in-Fact 12 Nov 2025 0001965703

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFST Common Stock Award $0 +76.1K +28.95% $0.00 339K 06 Mar 2025 Direct F1
transaction LFST Common Stock Tax liability -$50.9K -6.46K -1.9% $7.88 333K 06 Mar 2025 Direct F2
transaction LFST Common Stock Award $0 +27.7K +8.34% $0.00 360K 07 Mar 2025 Direct F3
transaction LFST Common Stock Tax liability -$56.5K -7.45K -2.07% $7.59 353K 07 Mar 2025 Direct F4
transaction LFST Common Stock Award $0 +32.1K +9.08% $0.00 385K 07 Mar 2025 Direct F5
transaction LFST Common Stock Tax liability -$65.3K -8.61K -2.24% $7.59 376K 07 Mar 2025 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 76,142 restricted stock units ("RSUs") granted on March 6, 2025. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2 Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of RSUs that vested on March 6, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.
F3 Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on March 8, 2024, which vested on March 7, 2025.
F4 Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 7, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.
F5 Represents PSUs previously granted to the Reporting Person on February 28, 2024, which vested on March 7, 2025.
F6 Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 7, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.

Remarks:

The Form 4 previously filed on March 10, 2025 reported that 3,725 shares were withheld by the Issuer to satisfy withholding tax obligations in connection with the net settlement of PSUs that vested on March 7, 2025 as 3,725 in the fourth row of table 1 above. This Form 4 is being filed to amend the number of shares withheld to be 7,450 and to update the number of shares reported as securities beneficially owned following the reported transaction.